ANDA 213356, held by Apotex. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 213356 (Metformin Hydrochloride), held by Apotex, was first approved by FDA on Dec 13, 2021, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 13, 2021 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride1GM · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Dec 13, 2024 | Supplement 1Labeling · Standard review | Approved | None posted |
| Dec 13, 2021 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters